TY - JOUR
T1 - Psychiatric co-morbidity and substance use disorders: Treatment in parallel systems or in one integrated system
AU - Torrens, Marta
AU - Rossi, Paola C.
AU - Martinez-Riera, Roser
AU - Martinez-Sanvisens, Diana
AU - Bulbena, Antoni
PY - 2012/6/1
Y1 - 2012/6/1
N2 - Psychiatric co-morbidity among substance users refers to the simultaneous presence of at least another psychiatric disorder in a person diagnosed with a substance use disorder. Co-morbid patients represent a substantial number of people in treatment and present greater disorder severity from both the clinical and social perspectives than those people diagnosed with only one type of disorder. We present an overview of the current state of the art concerning the choice of site of treatment, the kind of intervention, the length of such treatment, and future goals, aiming to establish a more effective intervention, and finally so as to further improve clinical outcomes. © 2012 Informa Healthcare USA, Inc.
AB - Psychiatric co-morbidity among substance users refers to the simultaneous presence of at least another psychiatric disorder in a person diagnosed with a substance use disorder. Co-morbid patients represent a substantial number of people in treatment and present greater disorder severity from both the clinical and social perspectives than those people diagnosed with only one type of disorder. We present an overview of the current state of the art concerning the choice of site of treatment, the kind of intervention, the length of such treatment, and future goals, aiming to establish a more effective intervention, and finally so as to further improve clinical outcomes. © 2012 Informa Healthcare USA, Inc.
KW - dual diagnosis
KW - psychiatric co-morbidity
KW - services
KW - substance use
KW - treatment
U2 - 10.3109/10826084.2012.663296
DO - 10.3109/10826084.2012.663296
M3 - Article
SN - 1082-6084
VL - 47
SP - 1005
EP - 1014
JO - Substance Use and Misuse
JF - Substance Use and Misuse
IS - 8-9
ER -